EXPLORING NOVEL BIOMARKERS FOR EARLY DISEASE DETECTION

Early recognition of illnesses is crucial for improving patient outcomes and reducing the burden of chronic conditions. , Classically, Historically, disease screening has relied on physical observations and destructive diagnostic tests. However, these approaches often fail to identify diseases in their preclinical stages, when therapy is significan